Expressive

rs1022581 - LINC01370 - MAFB

Magnitude 2.2 · 1 study on file

Reported associations

  • Participation bias in the UK Biobank distorts genetic associations and downstream analyses - Unknown journal (n.d.) · Unknown authors · PubMed 37106081

    ABSTRACT: While volunteer-based studies such as the UK Biobank have become the cornerstone of genetic epidemiology, the participating individuals are rarely representative of their target population. To evaluate the impact of selective participation, here we derived UK Biobank participation probabilities on the basis of 14 variables harmonized across the UK Biobank and a representative sample. We then conducted weighted genome-wide association analyses on 19 traits. Comparing the output from weighted genome-wide association analyses (neffective = 94,643 to 102,215) with that from standard genome-wide association analyses (n = 263,464 to 283,749), we found that increasing representativeness led to changes in SNP effect sizes and identified novel SNP associations for 12 traits. While

Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Diet

  • excess saturated and trans fats Moderate

    Dietary saturated and trans fats increase LDL, compounding genetic risk

    reduce to <7% of daily calories

  • plant sterols and soluble fiber Moderate

    rs1022581 increases LDL cholesterol; plant sterols and soluble fiber reduce LDL absorption

    target 2g plant sterols daily, increase oats, beans, fruit

Discuss with your doctor

  • cardiovascular risk and statin therapy options Moderate

    rs1022581 increases genetic LDL risk; doctor can assess total cardiovascular risk and recommend preventive therapy

Exercise

  • regular aerobic exercise Moderate

    Aerobic exercise reduces LDL and increases HDL, countering the LDL-raising effect of this variant

    150 minutes moderate intensity per week

Screening

  • lipid panel screening periodically Moderate

    Periodic LDL monitoring helps assess cardiovascular risk from this variant

    baseline at age 20, then every 5 years if normal, annually if elevated